社区老年获得性肺炎患者预后影响因素分析

Analysis of factors affecting the prognosis of elderly patients with acquired pneumonia in the community

目的探讨社区老年获得性肺炎患者预后效果及影响因素。方法选择医院2018年2月—2019年12月接诊的社区老年获得性肺炎患者200例为研究对象,根据预后结果分为预后不良组(死亡或恶化)和预后良好组,通过单因素和多因素Logistic回归分析筛选预后影响因素。结果单因素分析显示,社区老年获得性肺炎患者预后效果相关因素有年龄、合并心脑血管疾病、合并基础疾病、合并慢性阻塞性肺疾病(COPD)、低钠血症、低白蛋白血症、预警评估间歇、低年资护士(P<0.05);多因素Logistic回归分析显示,社区老年获得性肺炎患者预后的影响因素有年龄≥70岁、合并基础疾病、合并COPD、低钠血症、低白蛋白血症、预警评估间歇≥2d、低年资护士(<5年)。结论社区老年获得性肺炎患者预后影响因素有年龄≥70岁、合并基础疾病、合并COPD、低钠血症、低白蛋白血症、预警评估间歇≥2d、低年资护士(<5年),临床需加强预后影响因素识别。

Objective To explore the prognostic effect and influencing factors of elderly patients with acquired pneumonia in the community.Methods We selected 200 cases of patients with community-acquired pneumonia in hospital from February 2018 to December 2019 as the study objects.According to the prognostic results,they were divided into a poor prognosis group(death or deterioration)and a good prognosis group.Multivariate Logistic regression analysis was used to screen prognostic factors.Results Univariate analysis showed that the related factors for the prognosis of elderly patients with acquired pneumonia in the community included age,combined cardiovascular and cerebrovascular diseases,combined with underlying diseases,combined with COPD,hyponatremia,hypoalbuminemia,intermittence of warning assessment,and low-age nurses(P<0.05).Multivariate Logistic regression analysis showed that the influencing factor for the prognosis of elderly patients with acquired pneumonia in the community included age≥70 years old,combined with underlying diseases,combined with COPD,hyponatremia,hypoalbuminemia,intermittence of warning assessment≥2d,and low-age nurses(<5 years)(P<0.05).Conclusion The influencing factor for the prognosis of elderly patients with acquired pneumonia in the community included age≥70 years old,combined with underlying diseases,combined with COPD,hyponatremia,hypoalbuminemia,intermittence of warning assessment≥2d,and low-age nurses(<5 years).The identification of prognostic factors should be strengthened in clinical.